IPBiz mentioned in Nature Drug Discovery
See "Industry sweats after patent verdict : Nature Reviews Drug Discovery," concerning Ariad v. Lilly.
[IPBiz post 1650]
[IPBiz post 1650]
posted by Lawrence B. Ebert at 4:02 AM
Monday, June 12, 2006
About Me
- Name: Lawrence B. Ebert
I'm a patent lawyer located in central New Jersey. I have a J.D. from the University of Chicago and a Ph.D. from Stanford University, where I studied graphite intercalation compounds at the Center for Materials Research. I worked at Exxon Corporate Research in areas ranging from engine deposits through coal and petroleum to fullerenes. An article that I wrote in The Trademark Reporter, 1994, 84, 379-407 on color trademarks was cited by Supreme Court in Qualitex v. Jacobson, 514 US 159 (1995) and the methodology was adopted in the Capri case in N.D. Ill. An article that I wrote on DNA profiling was cited by the Colorado Supreme Court (Shreck case) and a Florida appellate court (Brim case). I was interviewed by NHK-TV about the Jan-Hendrik Schon affair. I am developing ipABC, an entity that combines rigorous IP analytics with study of business models, to optimize utilization of intellectual property. I can be reached at C8AsF5 at yahoo.com.
Previous Posts
- More on soot technology: JM's CCRT
- Further discussion of planned US research work in ...
- iPod patent wars?
- Patent on "Sully Direct Current" granted by USPTO?
- Human SCNT at Harvard
- New Jersey's Jack the Cat trees bear
- SF BizTimes on USPTO reform proposals on continuin...
- New York Yankees prevail on "Baby Bombers"
- Xerox wins in latest edition of Unistrokes-wars, t...
- New controversy in stem cell area: Klein's letter...
0 Comments:
Post a Comment
<< Home